SCTB35 injection

DRUG5 trials

Sponsors

Sinocelltech Ltd.

Conditions

DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL)NHL - Non-Hodgkin's LymphomaNon-Hodgkin Lymphoma, B-cellSystem Lupus Erythematosus

Phase 1

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Not yet recruitingNCT06318884

Sinocelltech Ltd.Non-Hodgkin Lymphoma, B-cell

Start: 2024-04-30End: 2027-12-31Target: 76Updated: 2024-03-22

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

RecruitingNCT06841042

Sinocelltech Ltd.System Lupus Erythematosus

Start: 2025-02-28End: 2028-10-31Target: 168Updated: 2025-02-21

SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma

Not yet recruitingNCT07819188

Sinocelltech Ltd.NHL - Non-Hodgkin's Lymphoma

Start: 2026-09-30End: 2029-09-30Target: 90Updated: 2026-09-14

Phase 3

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

RecruitingNCT07562022

Sinocelltech Ltd.Follicular Lymphoma (FL)

Start: 2026-06-09End: 2029-06-01Target: 93Updated: 2026-08-13

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

RecruitingNCT07570823

Sinocelltech Ltd.DLBCL - Diffuse Large B Cell Lymphoma

Start: 2026-06-04End: 2029-04-01Target: 101Updated: 2026-08-13